List of works by Giuseppe V Masucci

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts: National Harbor, MD, USA. 9-13 November 2016.

scientific article published on 8 December 2016

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

scientific article (publication date: November 2016)

A better immune reaction to Erbb-2 tumors is elicited in mice by DNA vaccines encoding rat/human chimeric proteins

scientific article published on 23 March 2010

A novel approach for HLA-A typing in formalin-fixed paraffin-embedded-derived DNA.

scientific article published on 07 February 2014

A phase I clinical trial combining dendritic cell vaccination with adoptive T cell transfer in patients with stage IV melanoma.

scientific article published on 4 July 2014

A phase I trial of DNA vaccination with a plasmid expressing prostate-specific antigen in patients with hormone-refractory prostate cancer.

scientific article published on August 2004

A short-term dietary supplementation of high doses of vitamin E increases T helper 1 cytokine production in patients with advanced colorectal cancer

scientific article

A short-term dietary supplementation with high doses of vitamin E increases NK cell cytolytic activity in advanced colorectal cancer patients.

scientific article published on 2 December 2006

A systematic approach to biomarker discovery; preamble to "the iSBTc-FDA taskforce on immunotherapy biomarkers".

scientific article

Active immunosurveillance in the tumor microenvironment of colorectal cancer is associated with low frequency tumor budding and improved outcome

scientific article

Alternating chemo-immunotherapy with temozolomide and low-dose interleukin-2 in patients with metastatic melanoma.

scientific article

Analysis of HLA class I-II haplotype frequency and segregation in a cohort of patients with advanced stage ovarian cancer

scientific article published on 01 September 2007

Cancer classification using the Immunoscore: a worldwide task force

scientific article

Clinical Performance of the Consensus Immunoscore in Colon Cancer in the Asian Population from the Multicenter International SITC Study

scientific article published in 2022

Complete and long-lasting clinical responses in immune checkpoint inhibitor-resistant, metastasized melanoma treated with adoptive T cell transfer combined with DC vaccination

scientific article published on 11 July 2020

Correlation between HLA-A2 gene frequency, latitude, ovarian and prostate cancer mortality rates.

scientific article

Correlation of HLA-A02* genotype and HLA class I antigen down-regulation with the prognosis of epithelial ovarian cancer

scientific article published on 19 January 2012

Defining the critical hurdles in cancer immunotherapy

scientific article published on 14 December 2011

Dendritic cells highly quoted on immunotherapy stock market

scientific article published on 01 January 2002

Development of a technology platform for large-scale clinical grade production of DC.

scientific article

Effects of human plasma proteins on maturation of monocyte-derived dendritic cells.

scientific article

Efficient Harvest of In Vivo IL-2-Activated CD3+ Lymphocytes for Adoptive Immunotherapy by Selective Leukapheresis (Lymphocytapheresis)

scientific article published on June 1, 1997

Emerging concepts in biomarker discovery; the US-Japan Workshop on Immunological Molecular Markers in Oncology

scientific article

Frequent loss of HLA-A2 expression in metastasizing ovarian carcinomas associated with genomic haplotype loss and HLA-A2-restricted HER-2/neu-specific immunity.

scientific article published on June 2006

Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015.

scientific article

Future perspectives in melanoma research: meeting report from the "Melanoma Bridge", Napoli, December 5th-8th 2013.

scientific article

Future perspectives in melanoma research: meeting report from the "Melanoma Bridge": Napoli, December 3rd-6th 2014.

scientific article published on 30 November 2015

GM-CSF at relatively high topic concentrations can significantly enhance the healing of surgically induced chronic wounds after radiotherapy

scientific article published on 01 January 2001

Genotyping of human leukocyte antigen (HLA) ancestral haplotypes as prognostic marker in cancer using PCR analysis.

scientific article

HLA class I and II expression in oropharyngeal squamous cell carcinoma in relation to tumor HPV status and clinical outcome

scientific article

HLA-A*02 in relation to outcome in human papillomavirus positive tonsillar and base of tongue cancer

scientific article published on May 2014

HLA-dependent tumour development: a role for tumour associate macrophages?

scientific article

Human leucocyte antigen (HLA) A2 as a negative clinical prognostic factor in patients with advanced ovarian cancer.

scientific article

Hydrogen peroxide secreted by tumor-derived macrophages down-modulates signal-transducing zeta molecules and inhibits tumor-specific T cell-and natural killer cell-mediated cytotoxicity

scientific article published on 01 June 1996

Immature immunosuppressive CD14+HLA-DR-/low cells in melanoma patients are Stat3hi and overexpress CD80, CD83, and DC-sign

scientific article published on 18 May 2010

Inhibition of activated/memory (CD45RO(+)) T cells by oxidative stress associated with block of NF-kappaB activation

scientific article

International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study

scientific article published in The Lancet

Ipilimumab treatment results in an early decrease in the frequency of circulating granulocytic myeloid-derived suppressor cells as well as their Arginase1 production.

scientific article published on 2 August 2013

Leakage around voice prosthesis in laryngectomees: treatment with local GM-CSF

scientific article published on 01 November 2001

Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015

scientific article

Multicenter International Society for Immunotherapy of Cancer Study of the Consensus Immunoscore for the Prediction of Survival and Response to Chemotherapy in Stage III Colon Cancer

scientific article published on 08 September 2020

Myeloid-derived suppressor cells and their role in CTLA-4 blockade therapy

scientific article published on 26 June 2014

Myeloid-derived suppressor cells impair the quality of dendritic cell vaccines.

scientific article published on 12 November 2011

New clinical applications of granulocyte-macrophage colony-stimulating factor.

scientific article published on September 1996

Non-classical HLA-class I expression in serous ovarian carcinoma: Correlation with the HLA-genotype, tumor infiltrating immune cells and prognosis

scientific article published on 25 July 2015

PD-1 checkpoint blockade in advanced melanoma patients: NK cells, monocytic subsets and host PD-L1 expression as predictive biomarker candidates

scientific article published on 28 August 2020

PD-L1 expression as a potential predictive biomarker

scientific article published on 01 October 2015

Perspectives in melanoma: Meeting report from the Melanoma Bridge (30 November-2 December, 2017, Naples, Italy)

scientific article published on 21 July 2018

Perspectives in melanoma: meeting report from the Melanoma Bridge (November 29th-1 December 1st, 2018, Naples, Italy)

scientific article published on 22 July 2019

Planning a Bayesian early-phase phase I/II study for human vaccines in HER2 carcinomas

scientific article

Prognostic Interactions between FAP+ Fibroblasts and CD8a+ T Cells in Colon Cancer

scientific article published on 03 November 2020

Prognostic significance of tumor iNOS and COX-2 in stage III malignant cutaneous melanoma.

scientific article published on 28 November 2008

Protein profiling of fine-needle aspirates reveals subtype-associated immune signatures and involvement of chemokines in breast cancer

scientific article published on 07 January 2019

Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers

scientific article

Stereotactic Ablative Radio Therapy (SABR) followed by immunotherapy a challenge for individualized treatment of metastatic solid tumours

scientific article published on 22 May 2012

Synthetic peptides derived from the melanocyte-stimulating hormone receptor MC1R can stimulate HLA-A2-restricted cytotoxic T lymphocytes that recognize naturally processed peptides on human melanoma cells

scientific article published on October 1997

The common Scandinavian human leucocyte antigen ancestral haplotype 62.1 as prognostic factor in patients with advanced malignant melanoma

scientific article

The need for a network to establish and validate predictive biomarkers in cancer immunotherapy

scientific article published on 3 November 2017

Therapeutic efficacy by recombinant human granulocyte/monocyte-colony stimulating factor on mucositis occurring in patients with oral and oropharynx tumors treated with curative radiotherapy: a multicenter open randomized phase III study

scientific article published on 01 January 2005

Towards the introduction of the 'Immunoscore' in the classification of malignant tumours

scientific article

Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1

scientific article published on 01 January 1999

Validation of the Immunoscore (IM) as a prognostic marker in stage I/II/III colon cancer: Results of a worldwide consortium-based analysis of 1,336 patients

Will modern cancer vaccines reach clinical practice?

scientific article published on 01 April 1999

World-Wide Immunoscore Task Force: meeting report from the "Melanoma Bridge", Napoli, November 30th-December 3rd, 2016

scientific article

[Paradigmatic shift in oncology: individualized melanoma treatment].

scientific article